DANIEL LEUNG to Cost-Benefit Analysis
This is a "connection" page, showing publications DANIEL LEUNG has written about Cost-Benefit Analysis.
Connection Strength
0.146
-
A Novel Luminescence-Based Serum Bactericidal Assay for Vibrio cholerae Reduces Assay Variation, Is Time- and Cost-Effective, and Directly Measures Continuous Titer Values. Am J Trop Med Hyg. 2021 07 08; 105(3):622-626.
Score: 0.146